Authors: Ravaud, A Borner, M Schellens, JHM Geoffrois, L Schoffski, BP Kroon, K Wanders, J Hanauske, AR Fumoleau, P

Citation: A. Ravaud et al., UFT and leucovorin in first-line chemotherapy for patients with metastaticgastric cancer. An Early Clinical Studies Group (ECSG)/European Organization for Research Treatment of Cancer (EORTC) phase II trial, EUR J CANC, 37(13), 2001, pp. 1642-1647

Authors: Spaeth, D Geoffrois, L Conroy, T

Citation: D. Spaeth et al., Prevention and treatment of hematological complications associated with oncological chemotherapy - News on hematopoietic growth factors, B CANCER, 87(1), 2000, pp. 93-96

Authors: Ravaud, A Borner, M Schellens, JHM Geoffrois, L Schoffski, P Wanders, J Hanauske, AR

Citation: A. Ravaud et al., UFT and oral calcium folinate as first-line chemotherapy for metastatic gastric cancer, ONCOLOGY-NY, 13(7), 1999, pp. 61-63

Authors: Ravaud, A Bedane, C Geoffrois, L Lesimple, T Delaunay, M

Citation: A. Ravaud et al., Toxicity and feasibility of adjuvant high dose interferon alpha-2b in patients with melanoma in clinical oncologic practice, BR J CANC, 80(11), 1999, pp. 1767-1769